GridAI Technologies Corp. GRDX

FY2025 · ended Dec 31, 2025 · Revenue $36,251 · Filed May 1, 2026

GridAI Technologies Corp. (GRDX) files with the SEC under industry code 4931, Electric & Other Services Combined. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $36,251 and a net loss of $6.4 million. As of Jun 30, 2026 it held $1.4 million in cash and investments and $1.8 million in total debt.

Revenue
$36,251
Net income
$-6.39M
+64.6% vs prior year
Operating cash flow (TTM)
$-8.12M
-180.7% vs year-ago TTM
Free cash flow
$-32.36M
-188.2% vs prior year
EPS (TTM)
$-9.69
-39.2% vs year-ago TTM
Dividend per share
None
Shares outstanding
6.20M
+30.1% vs prior year
Net cash
$-432,249
as of Jun 30, 2026
Operating margin
-19540.0%
FY 2025

Company profile

Industry
Electric & Other Services Combined (SIC 4931)
Listed as
GRDX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boca Raton, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1604191
Former names
Entero Therapeutics, Inc. (until Nov 19, 2025); First Wave BioPharma, Inc. (until May 16, 2024); AzurRx BioPharma, Inc. (until Sep 14, 2021); BioPharma d'Azur, Inc. (until Apr 2, 2014)

Other Electric & Other Services Combined companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$36,251
—
—
—
—
Operating income
-$7.1M
-$15.6M
-$15.8M
-$12.7M
-$59.1M
Net income
-$6.4M
-$18.1M
-$15.8M
-$14.6M
-$58.5M
Diluted EPS
-$4.16
-$15.99
-$47.88
-$416.94
-$1,988.53
Operating cash flow
-$5.7M
-$9.2M
-$12.4M
-$22.3M
-$32.3M
Free cash flow
—
—
—
—
-$32.4M
Total assets
$48.6M
$85.4M
$6.9M
$5.4M
$11.8M
Total liabilities
$19.7M
$27.6M
$3.3M
$2.7M
$19.6M
Stockholders' equity
$24.9M
—
—
—
—
Cash and investments
$899,784
$163,476
$3.7M
$1.4M
$8.2M
Total debt
$2.2M
$140,534
$214,060
$280,211
$389,127

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 30, 2026 Oct 26, 2026
8-K Current report
Material agreement
Oct 28, 2026 Oct 22, 2026
8-K Current report
Material agreement, Unregistered share sale
Oct 28, 2026 Oct 22, 2026
8-K Current report
Officer or director change
Oct 23, 2026 Oct 19, 2026
8-K Current report
Material agreement
Oct 7, 2026 Oct 1, 2026
10-Q/A Amended quarterly report Sep 18, 2026 Jun 30, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.